RNDr. Jan Mužík, Ph.D.
Research and development assistant, Institute of Biostatistics and Analyses
Total number of publications: 345
2013
-
Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials.
Leukemia & Lymphoma, year: 2013, volume: 54, edition: 10, DOI
-
Epidemiologie preventabilních zhoubných nádorů v ČR
Onkologie v gynekologii a mammologii, year: 2013
-
Estimation of the postpartum glucose intolerance risk in women with gestational diabetes mellitus using routine glycemic indices assessed in the mid-trimester of pregnancy
Year: 2013, type: Conference abstract
-
ESTIMATION OF THE RISK OF POSTPARTUM MATERNAL GLUCOSE INTOLERANCE IN WOMEN WITH GESTATIONAL DIABETES MELLITUS
Year: 2013, type: Conference abstract
-
Evaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels.
Cancer Medicine, year: 2013, volume: 2, edition: 2, DOI
-
Farmakoekonomické hodnocení (CEA) přípravku Vidaza (azacitidin) v terapii pacientů s myelodysplastickými syndromy v České republice – analýza nákladové efektivity a analýza dopadu na rozpočet veřejného zdravotního pojištění v letech 2013-2018.
Year: 2013
-
Genetics of anti-EHV antibody responses in a horse population
Research in Veterinary Sciences, year: 2013, volume: Vol. 95, edition: 1, DOI
-
Gliomy v datech národního onkologického registru ČR a klinické databáze České neurochirurgické společnosti ČLS JEP
Gliomy, edition: 1. vyd., year: 2013, number of pages: 10 s.
-
I-COPedu - Informační centrum onkologických pracovišť
Year: 2013
-
Invasive aspergillosis in patients with hematological malignacies in Czech and Slovak Republics? fungal infection database (find) analysis (2001-2011) - an update
Year: 2013, type: Conference abstract